Asymptomatic Plasmodium falciparum infection in children is associated with increased auto-antibody production, high IL-10 plasma levels and antibodies to merozoite surface protein 3

Malaria Journal

Volumn 14, Issue 1, 2015, Pages

  Guiyedi, Vincent ^a,b   Bécavin, Christophe ^c   Herbert, Fabien ^a   Gray, Julian ^d   Cazenave, Pierre André ^a   Kombila, Maryvonne ^b   Crisanti, Andrea ^d   Fesel, Constantin ^e   Pied, Sylviane ^a  

^a UNIV LILLE   (France)

^b Université des Sciences de la Santé   (Gabon)

^c INSTITUT PASTEUR   (France)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

^e INSTITUTO GULBENKIAN DE CIÊNCIA   (Portugal)

Author keywords

Antibody response; Auto antibody; Cytokines; Malaria; Plasmodium falciparum

Indexed keywords

AUTOANTIBODY; BRAIN ANTIGEN; GAMMA INTERFERON; IMMUNOGLOBULIN G; INTERLEUKIN 10; MEROZOITE SURFACE PROTEIN 3; MICROORGANISM PROTEIN; PARASITE ANTIBODY; PARASITE ANTIGEN; UNCLASSIFIED DRUG; IL10 PROTEIN, HUMAN; MEROZOITE SURFACE PROTEIN 3, PLASMODIUM; PROTOZOAL PROTEIN; PROTOZOON ANTIBODY;

ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ANTIGEN SPECIFICITY; ARTICLE; ASYMPTOMATIC INFECTION; BLOOD SMEAR; CHILD; CONTROLLED STUDY; CYTOKINE RESPONSE; FEMALE; GABONESE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALARIA CONTROL; MALARIA FALCIPARUM; MALE; PARASITE LOAD; PLASMODIUM FALCIPARUM; PRESCHOOL CHILD; SEX RATIO; BIOSYNTHESIS; BLOOD; ENZYME LINKED IMMUNOSORBENT ASSAY; GABON; IMMUNOLOGY; PARASITOLOGY; PHYSIOLOGY;

ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; ASYMPTOMATIC INFECTIONS; AUTOANTIBODIES; CHILD, PRESCHOOL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GABON; HUMANS; INFANT; INTERLEUKIN-10; MALARIA, FALCIPARUM; MALE; PLASMODIUM FALCIPARUM; PROTOZOAN PROTEINS;

EID: 84928709007     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/s12936-015-0658-7     Document Type: Article

References (36)

1. Miller LH, Ackerman HC, Su XZ, Wellems TE. Malaria biology and disease pathogenesis: insights for new treatments. Nat Med. 2013;19:156-67.
2. Schofield L, Mueller I. Clinical immunity to malaria. Curr Mol Med. 2006;6:205-21.
3. Good MF, Doolan D. Malaria vaccine design: immunological considerations. Immunity. 2010;33:555-66.
4. Wykes M, Good MF. Memory B cell responses and malaria. Parasite Immunol. 2006;28:31-4.
5. Crompton PD, Kayala MA, Traore B, Kayentao K, Ongoiba A, Weiss GE, et al. A prospective analysis of the Ab response to Plasmodium falciparum before and after a malaria season by protein microarray. Proc Natl Acad Sci U S A. 2010;107:6958-63.
6. Rolland L, Ballet JJ, Daniel-Ribeiro C. Kinetics of antigen specific and non-specific polyclonal B-cell responses during lethal Plasmodium yoelii malaria. Mem Inst Oswaldo Cruz. 1992;87:197-204.
7. Korir JC, Magambo JK, Mwatha JK, Waitumbi JN. B-cell activity in children with malaria. Malar J. 2012;11:66. doi: 10.1186/1475-2875-11-66.
8. Daniel-Ribeiro C, Druilhe P, Monjour L, Homberg JC, Gentilini M. Specificity of auto-antibodies in malaria and the role of polyclonal activation. Trans R Soc Trop Med Hyg. 1983;77:185-8.
9. Adu D, Williams DG, Quakyi IA, Voller A, Anim-Addo Y, Bruce-Tagoe AA, et al. Anti-ssDNA and antinuclear antibodies in human malaria. Clin Exp Immunol. 1982;49:310-6.
10. Adib-Conquy M, Avrameas S, Ternynck T. Monoclonal IgG and IgM autoantibodies obtained after polyclonal activation, show reactivities similar to those of polyclonal natural autoantibodies. Mol Immunol. 1993;30:119-27.
11. Semblat JP, Raza A, Kyes SA, Rowe JA. Identification of Plasmodium falciparum var1CSA and var2CSA domains that bind IgM natural antibodies. Mol Biochem Parasitol. 2006;146:192-7.
12. Weiss GE, Crompton PD, Li S, Walsh LA, Moir S, Traore B, et al. Atypical memory B cells are greatly expanded in individuals living in a malaria-endemic area. J Immunol. 2009;183:2176-82.
13. Duan B, Morel L. Role of B-1a cells in autoimmunity. Autoimmun Rev. 2006;5:403-40.
14. Gray JC, Corran PH, Mangia E, Gaunt MW, Li Q, Tetteh KK, et al. Influence of infection on malaria-specific antibody dynamics in a cohort exposed to intense malaria transmission in northern. J Clin Chem. 2007;3:1244-53.
15. Haury M, Grandien A, Sundblad A, Coutinho A, Nobrega A. Global analysis of antibody repertoires. 1. An immunoblot method for the quantitative screening of a large number of reactivities. Scand J Immunol. 1994;39:79-87.
16. Fesel C, Goulart LF, Silva Neto A, Coelho A, Fontes CJ, Braga EM, et al. Increased polyclonal immunoglobulin reactivity toward human and bacterial proteins is associated with clinical protection in human Plasmodium infection. Malar J. 2005;4:5.
17. Guiyedi V, Chanseaud Y, Fesel C, Snounou G, Rousselle JC, Lim P, et al. Self-reactivities to the non-erythroid alpha spectrin correlate with cerebral malaria in Gabonese children. PLoS One. 2007;2:e389.
18. Bansal D, Herbert F, Lim P, Deshpande P, Bécavin C, Guiyedi V, et al. IgG autoantibody to brain beta tubulin III associated with cytokine cluster-II discriminate cerebral malaria in central India. PLoS One. 2009;4:e8245. doi:10.1371/journal.pone.0008245.
19. Prakash D, Fesel C, Jain R, Cazenave PA, Mishra GC, Pied S. Clusters of cytokines determine malaria severity in Plasmodium falciparum-infected patients from endemic areas of Central India. J Infect Dis. 2006;194:198-207.
20. Rothstein TL, Griffin DO, Holodick NE, Quach TD, Kaku H. Human B-1 cells take the stage. Ann N Y Acad Sci. 2013;1285:97-114.
21. Daniel-Ribeiro CT, Zanini G. Autoimmunity and malaria: what are they doing together? Acta Trop. 2000;76:205-21.
22. Ternynck T, Falanga PB, Unterkirscher C, Gregoire J, da Silva LP, Avrameas S. Induction of high levels of IgG autoantibodies in mice infected with Plasmodium chabaudi. Int Immunol. 1991;3:29-37.
23. Stuart MK, Green TJ. Monoclonal IgM rheumatoid factor-like anti-globulins enhance the inhibitory effects of Plasmodium falciparum-specific monoclonal antibodies in vitro. Parasitology. 1990;2:177-85.
24. Baumgarth N, Tung JW, Herzenberg LA. Inherent specificities in natural antibodies: a key to immune defense against pathogen invasion. Springer Semin Immunopathol. 2005;26:347-62.
25. Okech BA, Corran PH, Todd J, Joynson-Hicks A, Uthaipibull C, Egwang TG, et al. Fine specificity of serum antibodies to Plasmodium falciparum merozoite surface protein, PfMSP-1(19), predicts protection from malaria infection and high-density parasitemia. Infect Immun. 2004;72:1557-67.
26. Giha HA, Nasr AA, Iriemenam NC, Berzins K, Troye-Blomberg M, Arnot DE, et al. A malaria serological map indicating the intersection between parasite antigenic diversity and host antibody repertoires. Eur J Clin Microbiol Infect Dis. 2012;31:3117-25.
27. Polley SD, Conway DJ, Cavanagh DR, McBride JS, Lowe BS, Williams TN, et al. High levels of serum antibodies to merozoite surface protein 2 of Plasmodium falciparum are associated with reduced risk of clinical malaria in coastal Kenya. Vaccine. 2006;24:4233-46.
28. Carvalho LJ, Alves FA, Bianco Jr C, Oliveira SG, Zanini GM, Soe S, et al. Immunization of Saimiri sciureus monkeys with a recombinant hybrid protein derived from the Plasmodium falciparum antigen glutamate-rich protein and merozoite surface protein 3 can induce partial protection with Freund and Montanide ISA720 adjuvants. Clin Diagn Lab Immunol. 2005;12:242-8.
29. Ntoumi F, Ekala MT, Makuwa M, Lekoulou F, Mercereau-Puijalon O, Deloron P. Sickle cell trait carriage: imbalanced distribution of IgG subclass antibodies reactive to Plasmodium falciparum family-specific MSP2 peptides in serum samples from Gabonese children. Immunol Lett. 2002;84:9-16.
30. Luzzi GA, Merry AH, Newbold CI, Marsh K, Pasvol G. Protection by alpha-thalassaemia against Plasmodium falciparum malaria: modified surface antigen expression rather than impaired growth or cytoadherence. Immunol Lett. 1991;30:233-40.
31. Crandall I, Guthrie N, Sherman IW. Plasmodium falciparum: sera of individuals living in a malaria-endemic region recognize peptide motifs of the human erythrocyte anion transport protein. Am J Trop Med Hyg. 1995;52:450-5.
32. Othoro C, Lal AA, Nahlen B, Koech D, Orago AS, Udhayakumar V. A low interleukin-10 tumor necrosis factor-alpha ratio is associated with malaria anemia in children residing in a holoendemic malaria region in western Kenya. J Infect Dis. 1999;179:279-82.
33. Linke A, Kühn R, Müller W, Honarvar N, Li C, Langhorne J. Plasmodium chabaudi chabaudi: differential susceptibility of gene-targeted mice deficient in IL-10 to an erythrocytic-stage infection. Exp Parasitol. 1996;84:253-63.
34. Garraud O, Perraut R, Diouf A, Nambei WS, Tall A, Spiegel A, et al. Regulation of antigen-specific immunoglobulin G subclasses in response to conserved and polymorphic Plasmodium falciparum antigens in an in vitro model. Infect Immun. 2002;70:2820-7.
35. Cham GK, Turner L, Lusingu J, Vestergaard L, Mmbando BP, Kurtis JD, et al. Sequential, ordered acquisition of antibodies to Plasmodium falciparum erythrocyte membrane protein 1 domains. J Immunol. 2009;183:3356-63.
36. Turner L, Wang CW, Lavstsen T, Mwakalinga SB, Sauerwein RW, Hermsen CC, et al. Antibodies against PfEMP1, RIFIN, MSP3 and GLURP are acquired during controlled Plasmodium falciparum malaria infections in naïve volunteers. PLoS One. 2011;6:e29025. doi: 10.1371/journal.pone.0029025.